comparemela.com

Latest Breaking News On - Diabetes obesity - Page 1 : comparemela.com

American pharma major Eli Lilly's big focus on India: Will the company's strategy work?

American pharma major Eli Lilly sees India as its launchpad for a new growth trajectory, using its new drugs for diabetes and obesity as the fuel. Will this strategic pivot work? - Issue Date: Mar 31, 2024

Germany
India
United-states
United-kingdom
Vietnam
Republic-of
Denmark
American
Danish
Sheetal-sapale
Lilly-indian
Sun-pharma

Six ways to provide successful s-learning programs to healthcare professionals

Six ways to provide successful s-learning programs to healthcare professionals
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Nottingham
United-kingdom
Sucharita-kundu
Richard-donnelly
Michael-kirby
Trends-in-urology-men-health
University-of-nottingham
Research-solutions
Google
Emeritus-professor
Diabetes-obesity
Senior-content-strategist

GLP-1RA Use Reduces HbA1c in Youth-Onset Type 2 Diabetes

GLP-1RA use was associated with reduced glycated hemoglobin levels across 6 months among pediatric patients with type 2 diabetes.

Drug-administration
Diabetes-obesity

Insulin Glargine for Dysglycemia Protects Against Cognitive Impairment

Insulin glargine for dysglycemia was associated with a reduced cognitive impairment risk after a median follow-up of 6.2 years.

Diabetes-obesity
Outcomes-reduction
Initial-glargine-intervention

Insulin Glargine for Dysglycemia Protects Against Cognitive Impairment

Insulin glargine for dysglycemia was associated with a reduced cognitive impairment risk after a median follow-up of 6.2 years.

Diabetes-obesity
Outcomes-reduction
Initial-glargine-intervention

vimarsana © 2020. All Rights Reserved.